G
GTBP
Gt Biopharma Inc
0.3690
-0.0213-5.46%After Hours: 0.3750 +0.0060 +1.63%19:26 04/10 EDT
OPEN/PREV CLOSE0.3999/0.3903
TODAY RANGE0.3605-0.4090
VOL980.72K
MARKET CAP11.64M
52 WEEK RANGE0.3605-3.850
AVG VOL (3M)1.09M
% TURNOVER3.11%
TURNOVER--
P/E (TTM)-0.0591
% RANGE12.43%
EPS(TTM)-6.2484
P/E(FORWARD)-1.1531
P/B1.628
BVPS0.2266
DIVIDEND--
P/S--
BETA--
DIV YIELD0.00%
FREE FLOAT MKT CAP11.19M
SHARES OUTSTANDING31.55M
NEXT EARNINGS05/13-05/18
FREE FLOAT30.32M
LOT SIZE1
EX-DATE02/05/2024
News
Press Releases
Financial Reports
Profile
TipRanks·4d ago
GT Biopharma Advances GTB-5550 via University Trial Pact
TipRanks·03/03 13:31
GT Biopharma price target lowered to $3 from $8 at Roth Capital
Seeking Alpha·03/02 19:42
GT Biopharma reports FY results
Benzinga·03/02 14:28
GT Biopharma Q4 EPS $(4.84) Down From $(1.66) YoY
Dow Jones·03/02 12:47
*GT Biopharma: Proforma Cash Balance as of Jan 31 About $9M >GTBP
Dow Jones·03/02 12:46
*GT Biopharma Yr Loss $28.4M >GTBP
TipRanks·03/02 12:12
GT Biopharma expects cash to fund operations through Q4 2026
Dow Jones·03/02 12:06
*GT Biopharma 2025 Research and Development Expenses About $3.5M >GTBP
Reuters·03/02 12:00
GT BIOPHARMA REPORTS FULL YEAR 2025 FINANCIAL RESULTS
Reuters·02/17 12:30
GT Biopharma to Present at Centurion One Capital Toronto Growth Conference